**Core tip:** The authors performed this meta-analysis to assess the incidence and characteristics of kidney stones in kidney transplant recipients. The estimated incidence of kidney stones in patients after kidney transplantation is 1.0%. Calcium based stones (CaOx and CaP) are the most common kidney stones after transplantation following by struvite stones and uric acid stones. The findings from this study may impact the management of kidney stone prevention after kidney transplantation.

INTRODUCTION
============

Kidney stones are one of the most common metabolic disorders and urological problems with a prevalence of 7.2%-7.7% in the adult population, and a ten-year recurrence rate of ≥ 30%\[[@B1]-[@B4]\]. The incidence of kidney stones is increasing especially in industrialized countries with an estimated global prevalence between 10%-15%\[[@B5]-[@B8]\]. Approximately 13% of men and 7% women will have a kidney stone during their lifetime\[[@B5],[@B8]\].

Previous studies have shown that stone recurrence rates may be lower, when glomerular filtration rate (GFR) reduced\[[@B9],[@B10]\]. Thus, patients with advanced chronic kidney disease (CKD) or end-stage kidney disease (ESRD) may encounter less stone disease\[[@B10]\], reported being as low as 0.68%\[[@B11]\]. After successful kidney transplantation, ESRD patients subsequently have significant improvement in renal function resulting in urinary excretion of metabolites that increases risk of stone disease. Studies have identified kidney stones in allograft kidney as one of the serious problems in kidney transplant recipients\[[@B12]-[@B40]\]. However, unlike the general population, the incidence and characteristics of kidney stones in kidney transplant recipients are not well studied. The aim of this meta-analysis was to appraise the incidence and types of kidney stones after kidney transplantation.

MATERIALS AND METHODS
=====================

Cheungpasitporn W and Thongprayoon C individually examined published studies and conference abstracts indexed in MEDLINE, EMBASE, and Cochrane Database from the inception of the databases through March 2016. The search strategy used is detailed in the supplementary material (Item 1). Further pertinent studies were retrieved by conducting a manual search using references from the articles that were reclaimed from the search strategy noted above. We followed the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines for systematic reviews and meta-analyses\[[@B41]\] and previously published guidelines\[[@B42],[@B43]\].

The inclusion criteria were as follows: (1) randomized controlled trials or observational studies (case-control, cross-sectional, cohort studies, or case series); (2) patient population age \> 18 years old; and (3) data on kidney stones in kidney transplant recipients were provided. The search was limited to English-language studies. Both published studies and conference abstracts were incorporated. Study eligibility was independently determined by the two investigators mentioned earlier. Differing decisions were settled by joint agreement.

A standardized information collection form was applied to derive the following data: The first author of each study, study design, year of publication, country where the study was conducted, number of kidney transplant recipients studied, number of patients with kidney stone, age and gender of patients with kidney stones, time of diagnosis after kidney transplantation, type of donor (Live or deceased donor), type and location of kidney stones, and period of follow-up.

Statistical analysis
--------------------

MetaXL software (EpiGear International Pty Ltd)\[[@B44]\] was utilized for data analysis. The incidence rates (IRs) and 95%CIs of adverse effects were reported using a DerSimonian-Laird random-effects model\[[@B45]\]. A random-effects model was implemented due to the high likelihood of inter-study variances. The Cochran Q test was completed to assess statistical heterogeneity. The *I*^2^ statistic was added to evaluate the degree of variation across studies related to heterogeneity instead of chance. An *I*^2^ of 0%-25% represents insignificant heterogeneity, 26%-50% low heterogeneity, 51%-75% moderate heterogeneity and \> 75% high heterogeneity\[[@B46]\]. To assess for publication bias funnel plots were used\[[@B47]\].

RESULTS
=======

Our search strategy yielded 1554 articles. Of these, 1397 articles were excluded following the review of their title and abstract based on their relevance and the eligibility criteria. The remaining 157 articles underwent full-length review, and an additional 136 were excluded for failing to meet the criteria. Twenty one articles\[[@B12]-[@B29],[@B36],[@B38],[@B40]\] met all inclusion criteria and were identified for the meta-analysis of kidney stones in kidney transplant recipients (Table [1](#T1){ref-type="table"}). Supplementary Item 2 outlines our search methodology and selection process.

###### 

Main characteristics of the studies included in this meta-analysis

  **Ref**.                           **Country**      **Year**   **Total number**                                             **No. of patients with kidney stone**                               **Time of diagnosis**                                                                       **Sex of patients with stone**   **Age of patients with stone**   **Donors**                                **Stone location**                                       **Stone composition**                                                                                                                                                                  **Mean follow-up time**
  ---------------------------------- ---------------- ---------- ------------------------------------------------------------ ------------------------------------------------------------------- ------------------------------------------------------------------------------------------- -------------------------------- -------------------------------- ----------------------------------------- -------------------------------------------------------- -------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -------------------------------
  Cho et al\[[@B12]\]                United States    1988       544                                                          9                                                                   Mean 14.7 mo, Median 7 mo (range 3-42 mo)                                                   6 male, 3 female                 Mean 30 yr (range 8-65 yr)       6 living, 3 cadaveric                     4 bladder, 3 kidney, 2 unknown                           4 calcium oxalate/calcium phosphate, 2 ammonium magnesium phosphate and carbonate appetite, 1 uric acid, 2 not studied                                                                 5 (range 1.5-15.5) yr
  Hayes et al\[[@B13]\]              United States    1989       892                                                          10                                                                  Mean 13 mo (range 4-49 mo)                                                                  7 male, 3 female                 Mean 29 yr (range 17-53 yr)      3 living, 7 cadaveric                     NR                                                       NR                                                                                                                                                                                     NR
  Harper et al\[[@B38]\]             United Kingdom   1994       178                                                          6                                                                   NR                                                                                          4 male, 1 female                 NR                               4 living, 1 cadaveric                     NR                                                       1 uric acid, 2 calcium phosphate, 1 calcium oxalate, 1 Magnesium ammonium phosphate                                                                                                    NR
  Shoskes et al\[[@B14]\]            United Kingdom   1995       812                                                          2                                                                   Mean 3.5 yr (range 2-5 yr)                                                                  NR                               Mean 40 yr                       NR                                        2 ureter                                                 NR                                                                                                                                                                                     At least 1 yr
  Benoit et al\[[@B36]\]             France           1996       1500                                                         12                                                                  NR                                                                                          7 male, 5 female                 Mean 36 yr                       2 living, 10 cadaveric                    5 calyces, 6 ureter, 1 pyeloureteral junction            4 calcium oxalate and phosphate, 2 struvite                                                                                                                                            NR
  Del Pizzo et al\[[@B15]\]          United States    1998       540 (445 renal transplant, 95 pancreas/renal transplant)     4                                                                   NR                                                                                          NR                               NR                               NR                                                                                                 NR                                                                                                                                                                                     NR
  Rhee et al\[[@B16]\]               United States    1999       1813 (1730 renal transplant, 83 pancreas/renal transplant)   8                                                                   NR                                                                                          4 male, 4 female                 Mean 51 yr (range 34-60 yr)      2 living, 1 cadaveric, 5 pancreas/renal   3 kidney, 1 ureter, 4 bladder                            1 uric acid, 1 calcium oxalate, 1 calcium oxalate/calcium phosphate, 1 calcium phosphate, 1 struvite stone, 3 unknown                                                                  Mean 68.6 mo (range 27-98 mo)
  El-Mekresh et al\[[@B17]\]         Egypt            2001       1200                                                         11                                                                  NR                                                                                          NR                               NR                               NR                                        3 kidney, 4 ureter, 4 bladder                            NR                                                                                                                                                                                     NR
  Kim et al\[[@B18]\]                United States    2001       849                                                          15                                                                  Mean 17.8 mo (range 3-109 mo)                                                               10 male, 5 female                Mean 41.5 yr (range 28-67 yr)    8 living, 7 cadaveric                     11 bladder, 3 kidney, 1 multiple sites                   5 mixed form of calcium oxalate and calcium phosphate, 1 calcium oxalate, 3 predominant calcium phosphate, 2 struvite, 2 mixed form of struvite and calcium phosphate, 2 not studied   Mean 58 mo (range 11-149 mo)
  Klinger et al\[[@B19]\]            Austria          2002       1027                                                         19 (4 diagnosis during transplant, 5 perioperative, 10 *de novo*)   For *de novo*: Mean 27.7 mo (range 13 to 48 mo)                                             8 male, 11 female                Mean 48.1 yr (range 26-72 yr)    1 living, 18 cadaveric                    14 kidney, 3 infundibulum, 1 distal ureter, 1 staghorn   11 calcium oxalate, 2 uric acid, 1 calcium phosphate, 5 not studied                                                                                                                    Mean 29 mo (range 14-48 mo)
  Doehn et al\[[@B20]\]              Germany          2002       1500                                                         11                                                                  NR                                                                                          5 male, 6 female                 Median 50 yr                     11 cadaveric                              NR                                                       3 uric acid, 3 calcium oxalate, 2 magnesium ammonium stone, 3 not studied                                                                                                              Median 4 yr
  Streeter et al\[[@B21]\]           United Kingdom   2002       1535                                                         12                                                                  For renal calculi: Median 150 d (range 56-1280 d); For bladder calculi: Range 8 mo - 4 yr   NR                               NR                               NR                                        9 ureter, 3 bladder                                      NR                                                                                                                                                                                     NR
  Abbott et al\[[@B22]\]             United States    2003       42906                                                        52                                                                  NR                                                                                          NR                               NR                                                                         35 kidney, 17 ureter                                     NR                                                                                                                                                                                     1.89 ± 1.15 yr
  Lipke et al\[[@B23]\]              United States    2004       500                                                          7                                                                   9 mo (range 1.5-26 mo)                                                                      7 female                         Mean 50 yr (range 8-73 yr)       4 living, 3 cadaveric                     7 bladder                                                7 mixed between calcium oxalate and calcium phosphate                                                                                                                                  NR
  Yigit et al\[[@B24]\]              Turkey           2004       125                                                          5 (2 preoperative, 1 early posttransplant, 2 *de novo*)             For *de novo*: Mean 6.5 mo (range 6-7 mo)                                                   3 male, 2 female                 Mean 35.2 yr                     NR                                        NR                                                       2 calcium oxalate, 1 uric acid, 2 infectious                                                                                                                                           Mean 32.4 mo
  Challacombe et al\[[@B25]\]        United Kingdom   2005       2085                                                         21                                                                  3.7 (0.17-18) yr                                                                            8 male, 13 female                Mean 41 yr (range 15-64 yr)      3 living, 18 cadeveric                    13 kidney, 7 ureter, 1 bladder                           NR                                                                                                                                                                                     NR
  Ferreira Cassini et al\[[@B26]\]   Brazil           2012       1313                                                         12 *de novo*                                                        Range 6 mo to 13 yr                                                                         8 males, 9 females               Mean 45.6 yr (range 32-63 yr)    2 living, 15 cadaveric                    6 calyces, 3 renal pelvis, 3 ureter                      NR                                                                                                                                                                                     NR
  Stravodimos et al\[[@B27]\]        Greece           2012       1525                                                         7                                                                   Mean 3.2 (2-7) yr                                                                           NR                               NR                               NR                                        5 kidney, 2 ureter                                       NR                                                                                                                                                                                     Mean 8 yr
  Cicerello et al\[[@B40]\]          Italy            2014       953                                                          10                                                                  NR                                                                                          4 male, 6 female                 Mean 43 yr                       NR                                        7 kidney, 3 ureter                                       NR                                                                                                                                                                                     NR
  Mamarelis et al\[[@B28]\]          Greece           2014       2045                                                         9                                                                   Mean 3.1 yr (range 1-7 yr)                                                                  NR                               NR                               NR                                        6 kidney, 3 ureter                                       NR                                                                                                                                                                                     6.6 yr (range 1-15 yr)
  Rezaee-Zavereh et al\[[@B29]\]     Iran             2015       574                                                          25                                                                  NR                                                                                          NR                               NR                               NR                                        NR                                                       NR                                                                                                                                                                                     55 ± 53 mo

CaOx: Calcium oxalate; CaP: Calcium phosphate; NR: Not reported.

Incidence of kidney stones in kidney transplant recipients
----------------------------------------------------------

The incidence of kidney stones after kidney transplantation within the 21 individual study ranged between 0.2% to 4.4% with an overall meta-analytical incidence of 1.0% (95%CI: 0.6%-1.4%)with evidence of a high level of heterogeneity (*I*^2^ = 93%, *P* \< 0.001; Figure [1](#F1){ref-type="fig"}).

![Forest plot of incidence of kidney stones in kidney transplant populations.](WJT-6-790-g001){#F1}

We performed a sensitivity analysis limited only to the studies that provided data on time of kidney stone diagnosis after kidney transplantation; the estimated incidence of kidney stones was 0.9% (95%CI: 0.7%-1.2%), and there was evidence of a high level of heterogeneity (*I*^2^ = 60%, *P* \< 0.001; Figure [2](#F2){ref-type="fig"}). The mean duration to diagnosis of kidney stones after kidney transplantation was 28 ± 22 mo.

![Forest plot of incidence of kidney stones in kidney transplant populations limited only to the studies that provided data on the time of kidney stone diagnosis after kidney transplantation.](WJT-6-790-g002){#F2}

Subgroup analyses by geographic information were also performed. The estimated incidences of kidney stones were 0.9% (95%CI: 0.3%-1.7%; *I*^2^ = 94%) and 0.7% (95%CI: 0.5%-0.9%; *I*^2^ = 40%) in the United States and Europe, respectively. Data on the incidence of kidney stones in kidney transplant recipients in other geographical area were limited as shown in Table [1](#T1){ref-type="table"}.

Characteristics of kidney transplant recipients with kidney stones
------------------------------------------------------------------

The mean age of patients with kidney stones was 42 ± 7 years. Within reported studies (Table [1](#T1){ref-type="table"}), approximately 50% of kidney transplant recipients with kidney stones were males.

Types of kidney stones in kidney transplant recipients
------------------------------------------------------

Sixty-seven percent of kidney stones were calcium-based stones (30% mixed CaOx/CaP, 27%CaOx and 10%CaP), followed by struvite stones (20%) and uric acid stones (13%) as shown in Table [1](#T1){ref-type="table"}.

Risk factors for kidney stones in kidney transplant recipients
--------------------------------------------------------------

Despite limited data on urinary supersaturation and risk factors for kidney stones, studies reported increased risk of kidney stones in kidney transplant recipients with hyperparathyroidism, hypercalciuria, hypocitraturia, hypophosphatemia, and urinary tract infection\[[@B28],[@B38]\]. Harper et al\[[@B38]\] found that urinary excretion of magnesium and phosphate was at the lower range for all kidney transplant recipients with kidney stones. Uncommonly, urinary outflow obstruction and foreign bodies were also found as risk factors for kidney stones in kidney transplant patients\[[@B28],[@B48]\].

Allograft failure in kidney transplant recipients with kidney stones
--------------------------------------------------------------------

As in general patient populations, kidney stones can also cause acute kidney injury in kidney transplant recipients\[[@B49]-[@B52]\]. Since kidney transplant recipients can have obstructed kidney stones without any symptom of pain\[[@B26],[@B28]\], prompt diagnosis and the removal of obstructed stones are the keys to preventing renal allograft failure\[[@B18]\]. Rezaee-Zavareh et al\[[@B29]\] reported no significant association between kidney stones after transplantation and graft survival (OR = 1.04; CI: 0.71-1.54). With the prompt removal of stones, Kim et al\[[@B18]\] found no significant changes in renal allograft function at diagnosis and after removal of kidney stones.

Evaluation for publication bias
-------------------------------

Funnel plot evaluating publication bias for the incidence of kidney stones in kidney transplant recipients demonstrated slight asymmetry of the graph and thus suggested the presence of publication for positive studies regarding the incidence of kidney stones.

DISCUSSION
==========

In this study, we demonstrated that an overall incidence of kidney stones in kidney transplant recipients was 1.0%. The mean age of recipients with kidney stones was 42, and half of stone formers were males. Calcium based (CaOx and CaP) stones were the most common types of kidney stones after kidney transplantation, followed by struvite stones and then uric acid stones.

The incidence of kidney stones after kidney transplantation from our meta-analysis is much lower than reported in the general adult populations\[[@B5]-[@B8]\]. Although the mechanisms behind the lower incidence of kidney stones after kidney transplantation, when compared with the general population, are only speculative, there are several plausible explanations. First, with the observation that new kidney stones are usually formed in transplanted allograft kidney but not in native non-functioning kidneys, kidney transplant recipients have significantly improved but still lower GFRs than those in healthy general populations, which may be "protective" for stone disease\[[@B9],[@B10]\]. Second, transplanted kidneys are from healthy donors ideally without tubulointerstitial defects, one not uncommon cause of kidney stones. Third, it is possible that kidney stones after kidney transplantation are underdiagnosed since recipients may spontaneously pass them from the transplanted kidney/ureter without pain or awareness.

Calcium based (CaOx and CaP) stones are the most common types of kidney stones in the general population as well as after kidney transplantation as demonstrated in our meta-analysis. Interestingly, struvite stones (ammonium magnesium phosphate) or "infection stones" is more common in kidney transplant recipients (20%) than in the general population (10%-15%)\[[@B53]\]. Since struvite stones are associated with infection with urea-splitting bacteria and the principles of treating struvite stones are different than other stones types, including removal of all stone fragments and use of antibiotics\[[@B53]\], this information is important for future studies targeting prevention and management of kidney stones after kidney transplantation.

There are several limitations to our study. First, there were statistical heterogeneities in the analysis of the incidence of kidney stones. The potential sources of this heterogeneity included differences in diagnostic methodology of kidney stones and follow-up duration. However, a sensitivity analysis that limited studies to those that only provided data on time of kidney stone diagnosis still showed a similar incidence rate of kidney stones, consistent with the finding of our primary analysis. Second, most included studies were conducted in developed Western countries with the majority of the subjects being Caucasian. Thus, our findings may not represent renal transplant populations from other parts of the world. Lastly, the data on urinary supersaturation and risk factors for kidney stones were limted. Although struvite stones represent an association with urinary tract infection, it is still unclear the risk factors for other stone types after kidney transplantation, and future studies are needed.

Our meta-analysis demonstrates that the estimated incidence of kidney stones in patients after kidney transplantation is 1.0%. Although calcium based stones are the most common kidney stones after transplantation, struvite stones are the second common type. These findings may impact clinical prevention and management of kidney stones in kidney transplant recipients.

COMMENTS
========

Background
----------

Renal stones are one of the most prevalent metabolic disorders and urological problems. However, with reduced kidney functions, patients with advanced chronic kidney disease (CKD) or end-stage kidney disease (ESRD) may encounter less stone disease. After successful kidney transplantation, ESRD patients have significant improvement in kidney functions and may develop kidney stones in their allograft kidney.

Research frontiers
------------------

The incidence and characteristics of kidney stones in kidney transplant recipients are not well studied. It is thus necessary to assess the incidence and types of kidney stones after kidney transplantation.

Innovations and breakthroughs
-----------------------------

In this study, the authors demonstrated that an overall incidence of kidney stones in kidney transplant recipients was 1.0%. The mean age of recipients with kidney stones was 42, and half of stone formers were males. Calcium based (CaOx and CaP) stones were the most common types of kidney stones after kidney transplantation, followed by struvite stones and then uric acid stones.

Applications
------------

The data in this study demonstrates an estimated incidence of kidney stones in patients after kidney transplantation of 1.0%. Calcium based stones and struvite stones are common types of kidney stones after transplantation. These findings may impact the clinical management of kidney stones prevention in kidney transplant recipients.

Terminology
-----------

CaOx: Calcium oxalate; CaP: Calcium phosphate; CKD: Chronic kidney disease; GFR: Glomerular filtration rate; NR: Not reported.

Peer-review
-----------

This is a reasonable first meta-analysis of incidence of kidney stones in kidney transplant recipients. The results have potential clinical applications.

Conflict-of-interest statement: All authors report no conflicts-of-interest.

Data sharing statement: No additional data are available.

Manuscript source: Invited manuscript

Specialty type: Transplantation

Country of origin: United States

Peer-review report classification

Grade A (Excellent): A

Grade B (Very good): B

Grade C (Good): 0

Grade D (Fair): D

Grade E (Poor): 0

Peer-review started: May 18, 2016

First decision: July 27, 2016

Article in press: October 24, 2016

P- Reviewer: Friedman EA, Shrestha BM, Watanabe T S- Editor: Kong JX L- Editor: A E- Editor: Lu YJ

[^1]: Author contributions: Cheungpasitporn W and Thongprayoon C contributed equally to this work; Cheungpasitporn W and Thongprayoon C: Performed the search, analysis and interpretation of data, analysis of data and final approval of the version to be published; Mao MA, Kittanamongkolchai W, Jaffer Sathick IJ and Dhondup T: Critical revising of the intellectual content and final approval of the version to be published; Erickson SB: Concept and design, critical revising of the intellectual content and final approval of the version to be published.

    Correspondence to: Wisit Cheungpasitporn, MD, Assistant Professor, Division of Nephrology and Hypertension, Department of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN 55905, United States. <wcheungpasitporn@gmail.com>

    Telephone: +1-507-2667093 Fax: +1-507-2667891
